The Application Notebook
Benzylideneacetophenone forms the central core for a variety of important biological compounds, known collectively as chalcones. Many of these compounds have significant medicinal value as they demonstrate antibacterial, antifungal, antitumor, and anti-inflammatory properties.
Benzylideneacetophenone forms the central core for a variety of important biological compounds, known collectively as chalcones. Many of these compounds have significant medicinal value as they demonstrate antibacterial, antifungal, antitumor, and anti-inflammatory properties. They are synthesized by an aldol condensation between a benzaldehyde and an acetophenone in the presence of NaOH as catalyst. In this application note, benzylideneacetophenone is isolated from a crude reaction mixture using flash chromatographic technique, including consideration for scale-up.
Figure 1: TLC of crude mixture.
TLC on silica gel Si60F254, developed in n-hexane/ethyl acetate 19:1, detection UV 254nm.
Cartridge 12 × 150 mm, prepacked with silica gel 60, 40–63 µm
2 Pump modules C-605
Fraction collector C-660
Control-Unit C-620 with SepacoreControl software
UV Photometer C-635
Figure 2: Separation 1.
Separation Conditions
Eluent: see below
Flow rate: 10 mL/min
100 mg crude mixture, dissolved in n-hexane and some drops of toluene (solubility of the sample in pure n-hexane too low)
Loading: approx. 0.4 mL
Separation 1
Eluent: n-hexane with 2% ethyl acetate, isocratic
Figure 3: Separation 2.
Separation 2
Eluent: n-hexane with 1%, 2% and 3% ethyl acetate, step gradient. Each step was initiated after a component was completely eluted (at the end of a peak).
TLC Check
TLC on silica gel Si60F254, developed in n-hexane/ethyl acetate 19:1, detection: UV 254 nm
1 = Benzaldehyde
2 = Benzylideneacetophenone
3= Benzophenone
Figure 4: TLC check of Separation 2.
Recovery
Fraction 7: 65 mg
Calculation of the scale-up factor
Cartridge 12 × 150 mm: cross sectional area = 1.13 cm2
Cartridge 40 × 150 mm: cross sectional area = 12.56 cm2
Scale-up-factor = 12.56 cm2 / 1.13 cm2 = 11.1 ≈ 10
Figure 5: Scale-up separation.
Separation conditions
Eluent: n-hexane with 1%, 2% and 3% ethyl acetate, step gradient
Sample: 1 g crude mixture, dissolved in n-hexane/toluene 7:3 (solubility of the sample in n-hexane too low, toluene is eluted as front peak)
Injection volume: 2 mL
Figure 6: TLC check of scale-up.
TLC-Check
TLC on silica gel Si60F254, developed in n-hexane/ethyl acetate 19:1, detection: UV 254 nm
Recovery
Fraction 13–16: 512 mg crystalline product, mp 57 °C
BUCHI Corporation
19 Lukens Drive, Suite 400, New Castle, DE 19720
tel. (302) 652-3000, fax (302) 652-8777
Website: www.mybuchi.com
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.